Amgen Inc. (AMGN) DCF Valuation

Amgen Inc. (AMGN) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

Amgen Inc. (AMGN) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Gain insights into your Amgen Inc. (AMGN) valuation analysis with our sophisticated DCF Calculator! Packed with real (AMGN) data, this Excel template lets you adjust forecasts and assumptions to accurately determine Amgen Inc. (AMGN) intrinsic value.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 23,362.0 25,424.0 25,979.0 26,323.0 28,190.0 29,559.1 30,994.6 32,499.9 34,078.2 35,733.2
Revenue Growth, % 0 8.83 2.18 1.32 7.09 4.86 4.86 4.86 4.86 4.86
EBITDA 12,633.0 12,929.0 12,542.0 12,093.0 14,702.0 14,856.4 15,577.9 16,334.4 17,127.7 17,959.5
EBITDA, % 54.07 50.85 48.28 45.94 52.15 50.26 50.26 50.26 50.26 50.26
Depreciation 2,206.0 3,601.0 3,398.0 3,261.0 4,071.0 3,754.9 3,937.3 4,128.5 4,329.0 4,539.3
Depreciation, % 9.44 14.16 13.08 12.39 14.44 12.7 12.7 12.7 12.7 12.7
EBIT 10,427.0 9,328.0 9,144.0 8,832.0 10,631.0 11,101.4 11,640.6 12,205.9 12,798.7 13,420.3
EBIT, % 44.63 36.69 35.2 33.55 37.71 37.56 37.56 37.56 37.56 37.56
Total Cash 8,911.0 10,647.0 8,037.0 9,305.0 10,944.0 10,944.5 11,476.0 12,033.3 12,617.7 13,230.5
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 4,057.0 4,525.0 4,895.0 5,563.0 7,942.0
Account Receivables, % 17.37 17.8 18.84 21.13 28.17
Inventories 3,584.0 3,893.0 4,086.0 4,930.0 9,518.0 5,845.3 6,129.1 6,426.8 6,738.9 7,066.2
Inventories, % 15.34 15.31 15.73 18.73 33.76 19.77 19.77 19.77 19.77 19.77
Accounts Payable 1,371.0 1,421.0 1,366.0 1,572.0 1,590.0 1,674.7 1,756.0 1,841.3 1,930.7 2,024.5
Accounts Payable, % 5.87 5.59 5.26 5.97 5.64 5.67 5.67 5.67 5.67 5.67
Capital Expenditure -618.0 -608.0 -880.0 -936.0 -1,112.0 -941.4 -987.2 -1,035.1 -1,085.4 -1,138.1
Capital Expenditure, % -2.65 -2.39 -3.39 -3.56 -3.94 -3.18 -3.18 -3.18 -3.18 -3.18
Tax Rate, % 14.49 14.49 14.49 14.49 14.49 14.49 14.49 14.49 14.49 14.49
EBITAT 8,948.2 8,331.3 8,041.4 7,877.4 9,090.8 9,719.9 10,192.0 10,687.0 11,206.0 11,750.2
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF 4,266.2 10,597.3 9,941.4 8,896.4 5,100.8 18,125.2 12,643.0 13,257.0 13,900.8 14,575.9
WACC, % 6.19 6.24 6.22 6.24 6.19 6.22 6.22 6.22 6.22 6.22
PV UFCF
SUM PV UFCF 61,036.6
Long Term Growth Rate, % 3.00
Free cash flow (T + 1) 15,013
Terminal Value 466,773
Present Terminal Value 345,262
Enterprise Value 406,299
Net Debt 53,669
Equity Value 352,630
Diluted Shares Outstanding, MM 538
Equity Value Per Share 655.45

What You Will Get

  • Real AMGN Financial Data: Pre-filled with Amgen’s historical and projected data for precise analysis.
  • Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
  • Automatic Calculations: See Amgen’s intrinsic value update instantly based on your changes.
  • Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
  • User-Friendly Design: Simple structure and clear instructions for all experience levels.

Key Features

  • Accurate Amgen Financials: Access reliable pre-loaded historical data and future projections for Amgen Inc. (AMGN).
  • Customizable Forecast Assumptions: Modify yellow-highlighted cells such as WACC, growth rates, and profit margins.
  • Dynamic Calculations: Automatic updates to DCF, Net Present Value (NPV), and cash flow analysis tailored for Amgen Inc. (AMGN).
  • Visual Dashboard: User-friendly charts and summaries to easily visualize your valuation results for Amgen Inc. (AMGN).
  • For Professionals and Beginners: An intuitive design crafted for investors, CFOs, and consultants focused on Amgen Inc. (AMGN).

How It Works

  • Download: Access the ready-to-use Excel file containing Amgen Inc.'s (AMGN) financial data.
  • Customize: Tailor forecasts, including revenue growth, EBITDA %, and WACC to your needs.
  • Update Automatically: The intrinsic value and NPV calculations adjust in real-time.
  • Test Scenarios: Generate multiple projections and compare results instantly.
  • Make Decisions: Leverage the valuation outcomes to inform your investment strategy.

Why Choose This Calculator for Amgen Inc. (AMGN)?

  • Comprehensive Tool: Incorporates DCF, WACC, and financial ratio analyses tailored for Amgen Inc. (AMGN).
  • Customizable Inputs: Modify yellow-highlighted cells to explore different financial scenarios specific to Amgen Inc. (AMGN).
  • Detailed Insights: Automatically computes Amgen Inc. (AMGN)’s intrinsic value and Net Present Value.
  • Preloaded Data: Historical and forecasted data provide reliable starting points for analysis of Amgen Inc. (AMGN).
  • Professional Quality: Perfect for financial analysts, investors, and business consultants focusing on Amgen Inc. (AMGN).

Who Should Use This Product?

  • Investors: Evaluate Amgen Inc.'s (AMGN) valuation prior to making investment decisions.
  • CFOs and Financial Analysts: Optimize valuation procedures and assess financial forecasts.
  • Startup Founders: Understand the valuation methods of large public companies like Amgen Inc.
  • Consultants: Create detailed valuation reports for your clients based on Amgen Inc.'s data.
  • Students and Educators: Utilize actual market data to learn and teach valuation strategies.

What the Template Contains

  • Pre-Filled DCF Model: Amgen Inc.’s financial data preloaded for immediate use.
  • WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
  • Financial Ratios: Evaluate Amgen Inc.’s profitability, leverage, and efficiency.
  • Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
  • Financial Statements: Annual and quarterly reports to support detailed analysis.
  • Interactive Dashboard: Easily visualize key valuation metrics and results.

No products were found matching.